Neumora Therapeutics, Inc.'s total assets for Q4 2024 were $316.97M, a decrease of -10.09% from the previous quarter. NMRA total liabilities were $29.91M for the fiscal quarter, a -5.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.